Gastroenterology — MCQs

Gastroenterology Indian Medical PG Practice Questions and MCQs

Question 1171: Which of the following is the most common screening test for acute pancreatitis?

A. Serum lipase (Correct Answer)
B. Urine trypsinogen
C. Insulin
D. Serum amylase

Explanation: ***Serum lipase*** - **Serum lipase** is considered the most specific and sensitive enzyme for diagnosing acute pancreatitis. [1] - Its levels typically rise within 4-8 hours of acute pancreatitis onset and can remain elevated for 8-14 days. [1] *Serum amylase* - While **serum amylase** is also elevated in acute pancreatitis, it is less specific than lipase as it can be elevated in other conditions (e.g., salivary gland disease, bowel ischemia). [1] - Its levels usually normalize more quickly than lipase, making it less useful for diagnosing pancreatitis with delayed presentation. [1] *Urine trypsinogen* - **Urine trypsinogen** can be elevated in pancreatitis, but it is not a routinely used or widely available screening test. [1] - Its diagnostic accuracy and clinical utility are not as well-established or practical as serum lipase or amylase. [1] *Insulin* - **Insulin** is a hormone produced by the pancreas involved in glucose regulation and is not a marker for pancreatic inflammation or injury in acute pancreatitis. - Its levels would not be used to diagnose acute pancreatitis.

Question 1172: How long after an attack of acute pancreatitis does a pancreatic pseudocyst typically develop?

A. Less than 1 week
B. Less than 2 weeks
C. 3 or more weeks
D. 4 or more weeks (Correct Answer)

Explanation: ***4 or more weeks*** - A **pancreatic pseudocyst** is a collection of pancreatic fluid that becomes encapsulated by a non-epithelialized fibrous wall. [1] - This encapsulation process typically takes **at least 4 weeks** to form after the initial acute pancreatitis attack. *Less than 1 week* - Within the first week of acute pancreatitis, the fluid collections are usually ill-defined, **peripancreatic fluid collections** without a well-formed wall. - These early collections are typically referred to as **acute peripancreatic fluid collections** (APFCs) or acute necrotic collections (ANCs) and do not meet the criteria for a pseudocyst. *Less than 2 weeks* - Fluid collections appearing within the first two weeks are still generally **unwalled** and do not have the characteristic fibrous capsule of a pseudocyst. [1] - They are considered acute fluid collections that may resolve spontaneously or evolve. *3 or more weeks* - While some organization might begin by 3 weeks, a **completely matured fibrous wall**, which defines a true pseudocyst, is generally not fully developed until **4 weeks or later**. - Collections at 3 weeks might still be evolving and may not yet be considered a stable pseudocyst.

Question 1173: Which of the following causes of acute pancreatitis can cause recurrent bouts without any obvious pathology?

A. Sphincter of Oddi dysfunction
B. Pancreas divisum
C. Hypertriglyceridemia
D. All of the options (Correct Answer)

Explanation: ***All of the options*** - **Sphincter of Oddi dysfunction**, **Pancreas divisum**, and **Hypertriglyceridemia** are all recognized causes of recurrent acute pancreatitis without always presenting obvious structural pathology on initial imaging like ultrasound or CT [1]. - These conditions can lead to repeated episodes of pancreatitis due to intermittent obstruction, abnormal pancreatic duct anatomy, or direct toxic effects, respectively, which may be difficult to diagnose without specific investigations [1]. *Sphincter of Oddi dysfunction* - This condition involves **spasms or stenosis of the sphincter of Oddi**, leading to impaired outflow of pancreatic and biliary secretions [1]. - The obstruction can be intermittent, causing recurrent attacks of pancreatitis without a visible stone or mass on routine imaging. *Pancreas divisum* - It is a **congenital anomaly** where the dorsal and ventral pancreatic ducts fail to fuse, leading to drainage of the dominant dorsal pancreas through a smaller accessory papilla. - This narrow opening can lead to **relative obstruction** and recurrent episodes of acute pancreatitis, especially when the main drainage is through the minor papilla. *Hypertriglyceridemia* - Significantly elevated levels of **triglycerides (typically >1000 mg/dL)** can directly cause damage to pancreatic acinar cells. - This condition can precipitate recurrent bouts of acute pancreatitis, and the underlying hypertriglyceridemia may not always be immediately recognized as the cause without specific lipid panel testing.

Question 1174: Which of the following is a common prognostic factor for Acute Pancreatitis?

A. Serum Glucose
B. Serum AST
C. Serum Amylase
D. Serum Calcium (Correct Answer)

Explanation: ### Serum Calcium - **Hypocalcemia** is a common **prognostic indicator** in severe acute pancreatitis, often due to saponification of fat by pancreatic lipases, leading to calcium precipitation [1]. - A persistent decrease in serum calcium levels can correlate with a **worse prognosis** and increased risk of complications [1]. *Serum Amylase* - While **elevated serum amylase** is diagnostic of acute pancreatitis, its absolute level **does not correlate with disease severity** or prognosis. - Amylase levels can return to normal even while the patient is still very ill with severe pancreatitis. *Serum Glucose* - **Hyperglycemia** can occur in acute pancreatitis due to impaired insulin secretion or increased counter-regulatory hormones, and may be included in some severity scoring systems [1]. - However, it is generally considered **less sensitive or specific** as a standalone prognostic factor compared to other markers like calcium. *Serum AST* - **Elevated AST** (and ALT) typically indicates a **biliary etiology** for acute pancreatitis, such as gallstones. - While it helps determine the cause, **AST levels themselves are not a primary prognostic factor** for the overall severity or outcome of the pancreatitis.

Question 1175: What disease is associated with ascitic fluid SAAG < 1.1?

A. Peritoneal carcinomatosis (Correct Answer)
B. Liver failure
C. Portal vein thrombosis
D. Tuberculosis peritonitis

Explanation: Peritoneal carcinomatosis - A serum-ascites albumin gradient (SAAG) less than 1.1 g/dL indicates that the ascites is not due to portal hypertension [1]. - In peritoneal carcinomatosis, the malignant cells in the peritoneum disrupt the normal fluid exchange, leading to fluid accumulation that is low in albumin relative to serum [1]. Liver failure - Liver failure, especially when leading to cirrhosis, is typically associated with portal hypertension and a SAAG ≥ 1.1 g/dL [1]. - The high SAAG reflects the increased hydrostatic pressure in the hepatic sinusoids, forcing fluid low in protein into the peritoneal cavity [1]. Portal vein thrombosis - Portal vein thrombosis causes portal hypertension and would therefore be associated with a high SAAG (≥ 1.1 g/dL) [1]. - The obstruction of the portal vein leads to increased sinusoidal hydrostatic pressure, similar to other causes of portal hypertension [1]. Tuberculosis peritonitis - Tuberculosis peritonitis is an inflammatory condition that can cause ascites, but it is typically associated with a SAAG < 1.1 g/dL [1]. - This is because the inflammatory process in the peritoneum allows for the leakage of albumin into the ascitic fluid, diminishing the gradient [1].

Question 1176: Portal hypertension is said to be present if portal venous pressure is more than:

A. 10 mm Hg (Correct Answer)
B. 3-5 mm Hg
C. 5-10 mm Hg
D. 12-15 mm Hg

Explanation: ***10 mm Hg*** - Portal hypertension is defined by a **hepatic venous pressure gradient (HVPG)** greater than 5 mmHg, but significant clinical consequences usually arise when the **portal venous pressure** exceeds **10 mmHg** [1]. - A persistent elevation above this threshold leads to the development of complications such as **ascites**, **varices**, and **splenomegaly** [1]. *3-5 mm Hg* - A portosystemic gradient of 3-5 mmHg is considered **normal portal pressure**, indicating no significant obstruction or resistance to portal flow [1]. - Pressures within this range do not cause the clinical manifestations associated with portal hypertension. *5-10 mm Hg* - While a **hepatic venous pressure gradient (HVPG)** greater than 5 mmHg technically defines portal hypertension, clinical symptoms typically do not appear until the pressure exceeds 10 mmHg [1]. - This range represents **mild portal hypertension** which may not be clinically significant. *12-15 mm Hg* - Pressures in the range of 12-15 mmHg indicate **severe portal hypertension**, which is often associated with a high risk of complications such as **esophageal variceal bleeding**. - This is a critical threshold for developing serious clinical sequelae, not the lower limit for defining portal hypertension.

Question 1177: All of the following drugs may be used in the treatment of ulcerative colitis except:

A. Corticosteroids
B. Sulfasalazine
C. Methotrexate (Correct Answer)
D. Azathioprine

Explanation: ***Methotrexate*** - While methotrexate is an immunosuppressant used in some autoimmune conditions, it is **not a first-line or commonly used drug for ulcerative colitis**. [2] - Its role in inflammatory bowel disease is primarily established for **Crohn's disease**, not ulcerative colitis. *Corticosteroids* - **Corticosteroids** are commonly used for inducing remission in **moderate to severe ulcerative colitis** due to their potent anti-inflammatory effects. [1] - They are effective for short-term management of flares but are not suitable for long-term maintenance therapy due to significant side effects. *Sulfasalazine* - **Sulfasalazine** is an aminosalicylate (5-ASA) drug, frequently used for the **induction and maintenance of remission in mild to moderate ulcerative colitis**. [1] - It works by reducing inflammation in the colon. *Azathioprine* - **Azathioprine** is an immunosuppressant often used for **maintaining remission in moderate to severe ulcerative colitis** when corticosteroids cannot be tapered or are ineffective. - It helps reduce the need for long-term corticosteroid use and can prevent disease flares.

Question 1178: Phlegmonous gastritis occurs due to?

A. H. pylori
B. Staphylococcus aureus
C. Streptococcus species (Correct Answer)
D. Clostridium perfringens

Explanation: **Streptococcus species** - **Phlegmonous gastritis** is a **rare, severe bacterial infection** of the stomach wall often caused by **Streptococcus species**. - These bacteria invade the gastric submucosa, leading to **purulent inflammation** and potential perforation. *H. pylori* - **H. pylori** is a common cause of **chronic gastritis**, peptic ulcers, and is associated with gastric cancer and MALT lymphoma [1]. - It typically causes **superficial inflammation** rather than invasive, purulent infection of the stomach wall [1]. *Staphylococcus aureus* - **Staphylococcus aureus** is a common cause of **food poisoning** due to its secreted toxins, which cause rapid onset of nausea, vomiting, and diarrhea [3]. - While it can cause other severe infections, it is **not a primary pathogen** for phlegmonous gastritis. *Clostridium perfringens* - **Clostridium perfringens** is known for causing **gas gangrene** and certain types of **food poisoning** (especially anaerobic cellulitis and myonecrosis) [2]. - It is **not typically implicated** in the severe, purulent inflammation of phlegmonous gastritis.

Question 1179: Blood group most commonly associated with gastric carcinoma is

A. Blood Group 0
B. Blood group A (Correct Answer)
C. Blood group AB
D. Blood group B

Explanation: ***Blood group A*** - Individuals with **blood group A** have been statistically shown to have a higher risk of developing **gastric carcinoma**. - This association is thought to be related to the presence of **A antigens**, which may influence cell adhesion and immune response in the gastric mucosa. *Blood Group O* - Blood group O is more commonly associated with an increased risk of **peptic ulcer disease**, particularly **duodenal ulcers**. - It does not show a strong positive correlation with the development of gastric carcinoma. *Blood group AB* - Blood group AB is the rarest blood type and the association with gastric carcinoma risk is not as significant or well-established compared to blood group A. - While showing some increased risk, it is less pronounced than for blood group A. *Blood group B* - Individuals with blood group B do not show a significant or commonly acknowledged increased risk for gastric carcinoma. - Research has not identified a strong correlation between blood group B and the development of this type of cancer.

Question 1180: Gold standard investigation for chronic pancreatitis?

A. Endoscopic Ultrasound (EUS)
B. MRI (Magnetic Resonance Imaging)
C. Endoscopic Retrograde Cholangiopancreatography (ERCP) (Correct Answer)
D. Pancreatic function tests

Explanation: ***Endoscopic Retrograde Cholangiopancreatography (ERCP)*** - ERCP is considered the **gold standard** for diagnosing chronic pancreatitis due to its ability to directly visualize the pancreatic duct system and detect subtle changes [1]. - It allows for direct imaging of ductal abnormalities like **strictures**, **dilatations**, and **calculi**, which are characteristic of chronic pancreatitis [1]. *MRI (Magnetic Resonance Imaging)* - While MRI, particularly **MRCP (Magnetic Resonance Cholangiopancreatography)**, is excellent for visualizing the pancreatic duct, it is generally less sensitive than ERCP for early or subtle changes in chronic pancreatitis [1]. - It is a **non-invasive** imaging technique but lacks the therapeutic and detailed ductal visualization capabilities of ERCP [1]. *Endoscopic Ultrasound (EUS)* - EUS is highly sensitive for detecting early parenchymal and ductal changes in chronic pancreatitis, such as **lobularity**, **stranding**, and small calculi. - Although it has high sensitivity, it is not considered the gold standard due to its operator dependence and inability to directly intervene or provide detailed ductal morphology as precisely as ERCP. *Pancreatic function tests* - Pancreatic function tests, such as the **secretin stimulation test**, assess the **exocrine function** of the pancreas by measuring enzyme or bicarbonate output [1]. - These tests are **indirect measures** of pancreatic damage and do not provide anatomical information about the pancreatic duct or parenchyma, making them less definitive for diagnosis compared to imaging [1].

Practice by Chapter

Esophageal Disorders

Practice Questions

Peptic Ulcer Disease

Practice Questions

Inflammatory Bowel Disease

Practice Questions

Irritable Bowel Syndrome

Practice Questions

Malabsorption Syndromes

Practice Questions

Pancreatitis (Acute and Chronic)

Practice Questions

Gastrointestinal Bleeding

Practice Questions

Liver Diseases and Cirrhosis

Practice Questions

Viral Hepatitis

Practice Questions

Biliary Tract Disorders

Practice Questions

Gastrointestinal Motility Disorders

Practice Questions

Gastrointestinal Malignancies

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free